STOCKHOLM, Sweden, Aug. 13, 2003 (PRIMEZONE) -- The Board of Directors appointed Dr. Magnus Nilsson CEO of Vitrolife AB (publ). Magnus Nilsson was previously Acting CEO of Vitrolife since January 3, 2003.
Gothenburg, Sweden, August 13, 2003
The Board of Directors, Vitrolife AB (publ)
For further information, please contact; CEO, Dr. Magnus Nilsson Chairman of the Board, Phone: +46 31 721 80 00 Patrik Tigerschiold Mobile +46 708 22 80 61 Phone: +46 8 614 00 20
Vitrolife is a global biomedical corporation that works with products for cell and tissue technology. The Vitrolife group consists of the parent company, Vitrolife AB (Publ) and four wholly owned subsidiaries: Vitrolife Sweden AB (Gothenburg, Sweden), Vitrolife Inc. (Denver, Colorado), A-Life Ltd. (Edinburgh, Scotland), and A-Life Inc. (Newport Beach, California). The group's operations focus on three geographic areas.
-- Europe/Middle East -- The Americas -- Rest of the World
Vitrolife's business concept is to develop, produce and sell advanced products and systems for the preparation, cultivation, preservation and support of cells, tissues and organs.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2003/08/13/20030813BIT00740/wkr0001.doc
http://www.waymaker.net/bitonline/2003/08/13/20030813BIT00740/wkr0002.pdf